The Office of Investigations and Analysis writes about the challenges facing employers to conduct mandatory drug testing during the COVID-19 pandemic response. In this article they explain options to maintain compliance in this challenging environment.
MSIB 09-20 Vessel Inspections, Exams, and Documentation
The Coast Guard has released guidance regarding its current position on commercial vessel compliance activities during the COVID-19 response.
Eighth District MSIB: Novel Coronavirus
The Eighth District Officer in Charge, Marine Inspection (OCMI) of the Outer Continental Shelf issued Marine Safety Information Bulletin 20-01, “Novel Coronavirus,” to alert offshore operators of protocols and requirements regarding novel coronavirus.
MSIB: Novel Coronavirus – Port and Facility Operations
The facility compliance regulations outlined throughout 33 Code of Federal Regulations remains in force, and facility operators are expected to continue to comply with these requirements as it relates to COVID-19.
MSIB: Novel Coronovirus – Mariner Credentials
The Coast Guard has published MSIB 08-20 to provide guidance concerning mariner credentials and medical certificates and the action being taken by the Coast Guard due to the novel coronavirus and the disease it causes (COVID-19).
Novel Coronavirus – Update (Change 3)
The Coast Guard Assistant Commandant for Prevention Policy has published an update March 16, 2020 to MSIB: Novel Coronavirus – Update (Change 2)
MSIB: Novel Coronavirus – Update (Change 2)
The Coast Guard Assistant Commandant for Prevention Policy has published an update March 9, 2020 to MSIB: Novel Coronavirus – Update (Change 1)
MSIB: Vessel reporting requirements for illness or death
The Coast Guard Assistant Commandant for Prevention Policy has published Marine Safety Information Bulletin 06-20, “Vessel Reporting Requirements for Illness or Death.”
MSIB: Novel Coronavirus – Update (Change 1)
The Coast Guard Director of Emergency Management published an update March 9, 2020 to Marine Safety Information Bulletin 02-20, “Novel Coronavirus.”
